MODULAR ATP Study Of The MCRM System Meets Primary Safety An

Additional data from APPRAISE ATP trial reinforce modular therapy approach with EMBLEM Subcutaneous Implantable Defibrillator and EMPOWER Leadless Pacemaker

Related Keywords

Amsterdam , Noord Holland , Netherlands , Boston , Massachusetts , United States , Kenneth Stein , Reinoud Knops , Linkedin , Boston Scientific , Boston Scientific Corporation , Securities Exchange , Exchange Commission , Twitter , Heart Rhythm Society , Department Of Cardiology , Drug Administration , Implantable Defibrillator , Heart Rhythm , New England Journal , European Economic , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports ,